Amphastar Pharmaceuticals (AMPH) Accumulated Expenses (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Accumulated Expenses of $117.2 million for Q1 2026, down 4.82% year-over-year from $123.1 million in Q1 2025, and up 1.24% quarter-over-quarter from $115.8 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Accumulated Expenses (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Accumulated Expenses history runs 14 years deep, the most recent figure standing at $117.2 million for Q1 2026.
- In Q1 2026, Accumulated Expenses fell 4.82% year-over-year to $117.2 million; the TTM figure through Mar 2026 stood at $117.2 million (down 4.82% YoY), while the FY2025 annual figure was $115.8 million, down 8.52% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $117.2 million, up from $115.8 million in the prior quarter.
- The five-year high for Accumulated Expenses was $198.7 million in Q2 2023, with the low at $63.7 million in Q4 2022.
- The 5-year median for Accumulated Expenses is $115.8 million (2025), against an average of $109.3 million.
- The sharpest annual moves came in 2023 and 2024: Accumulated Expenses jumped 198.38% in 2023, then tumbled 49.96% in 2024.
- Amphastar Pharmaceuticals' Accumulated Expenses stood at $63.7 million in 2022, then increased by 6.57% to $67.9 million in 2023, then surged by 86.29% to $126.5 million in 2024, then declined by 8.52% to $115.8 million in 2025, then grew by 1.24% to $117.2 million in 2026.
- Business Quant data shows AMPH's Accumulated Expenses at $117.2 million in Q1 2026, $115.8 million in Q4 2025, and $150.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Amphastar Pharmaceuticals | 945.98 Mn | 655.86 Mn | 93.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 222.44 Mn |
| Mar 31, 2026 | 117.19 Mn |
| Dec 31, 2025 | 115.76 Mn |
| Sep 30, 2025 | 150.30 Mn |
| Jun 30, 2025 | 124.67 Mn |
| Mar 31, 2025 | 123.13 Mn |
| Dec 31, 2024 | 126.54 Mn |
| Sep 30, 2024 | 119.18 Mn |
| Jun 30, 2024 | 99.44 Mn |
| Mar 31, 2024 | 80.16 Mn |
| Dec 31, 2023 | 67.93 Mn |
| Sep 30, 2023 | 190.75 Mn |
| Jun 30, 2023 | 198.70 Mn |
| Mar 31, 2023 | 66.91 Mn |
| Dec 31, 2022 | 63.74 Mn |
| Sep 30, 2022 | 75.83 Mn |
| Jun 30, 2022 | 66.59 Mn |
| Mar 31, 2022 | 71.97 Mn |
| Dec 31, 2021 | 67.33 Mn |
| Sep 30, 2021 | 67.25 Mn |